Document is current
Any future updates will be listed below
-
Authors
Adolf, Frank http://orcid.org/0000-0002-9812-5711
Du, Jiale http://orcid.org/0000-0003-1410-7020
Goodall, Ellen A. http://orcid.org/0000-0001-9876-5973
Walsh, Richard M. Jr http://orcid.org/0000-0002-8939-8988
Rawson, Shaun http://orcid.org/0000-0002-2973-2630
von Gronau, Susanne
Harper, J. Wade http://orcid.org/0000-0002-6944-7236
Hanna, John http://orcid.org/0000-0003-2964-1058
Schulman, Brenda A. http://orcid.org/0000-0002-3083-1126
- License Information
-
More Information
Article History
Received: 5 November 2023
Accepted: 6 March 2024
First Online: 10 April 2024
Competing interests
: J.W.H. is a founder and consultant for Caraway Therapeutics. B.A.S. is on the scientific advisory boards of Biotheryx and Proxygen. The other authors declare no competing interests.
